☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Tubulis Reports the First Patient Dosing with TUB-040 in P-I/IIa Study to Treat Ovarian Cancer and Lung Adenocarcinoma-bbb
Share this
PS Admin
Jun 20, 2024
Clinical Trials
Tubulis Reports the First Patient Dosing with TUB-040 in P-I/IIa Study to Treat Ovarian Cancer and Lung Adenocarcinoma-bbb
Click here
to read the full press release
Comments
Fill this Details
×
Name
Email
Company Name
Thank you for download PDF
Submit
Related News/Articles
Tubulis Reports the US FDA’s Fast Track Designation of TUB-040 to Treat Ovarian Cancer
June 28, 2024
Tubulis Reports the First Patient Dosing with TUB-040 in P-I/IIa Study to Treat Ovarian Cancer and Lung Adenocarcinoma-aa
June 20, 2024
Abbott Commences New Clinical Trial to Enhance Patient Outcomes in Advanced Heart Failure
October 25, 2024
Dyno Therapeutics Collaborates with Roche to Develop AAV Gene Therapy Vectors for Neurological Diseases
October 25, 2024
Accent Therapeutics Receives the US FDA’s IND Approval of ATX-559 for Treating Breast Cancer
October 25, 2024
Poseida Therapeutics to Feature Non-Clinical Data of P-KLKB1-101 for Treating Hereditary Angioedema at ACAAI 2024
October 25, 2024
EydisBio Receives $0.5M Grant to Support the Development of TAK1 Inhibitor Program for Alzheimer's Disease
October 24, 2024
Unlocking Approval: Baldo Scassellati Sforzolini from Galderma in a Stimulating Dialogue Exchange with PharmaShots
October 23, 2024
GSK Enters into a 5-Year Partnership with Cambridge University to Address Kidney and Respiratory Diseases
October 22, 2024
Enhancing Accessibility: Mark Mikhael from Olympia Pharmaceuticals in a Riveting Conversation with PharmaShots
October 21, 2024
Liked our insights or summarized news?
Subscribe to our Daily/Weekly newsletter
×
First Name
Last Name
Daily Newsletter
Weekly Newsletter
I agree to the privacy policy and terms.(
Link
)
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions
X
Liked our insights or summarized news?
Subscribe to our Daily/Weekly newsletter
Subscribe
Modal title
×
Modal body text goes here.